ENTRY       D12010                      Drug
NAME        Pacanalotamab (USAN)
FORMULA     C2373H3584N654O747S14
EXACT_MASS  53641.8655
MOL_WEIGHT  53674.6917
SEQUENCE    QVQLVQSGAE VKKPGASVKV SCKASGYTFT NHIIHWVRQA PGQGLEWMGY INPYPGYHAY
            NEKFQGRATM TSDTSTSTVY MELSSLRSED TAVYYCARDG YYRDTDVLDY WGQGTLVTVS
            SGGGGSGGGG SGGGGSDIQM TQSPSSLSAS VGDRVTITCQ ASQDISNYLN WYQQKPGKAP
            KLLIYYTSRL HTGVPSRFSG SGSGTDFTFT ISSLEPEDIA TYYCQQGNTL PWTFGQGTKV
            EIKSGGGGSE VQLVESGGGL VQPGGSLKLS CAASGFTFNK YAMNWVRQAP GKGLEWVARI
            RSKYNNYATY YADSVKDRFT ISRDDSKNTA YLQMNNLKTE DTAVYYCVRH GNFGNSYISY
            WAYWGQGTLV TVSSGGGGSG GGGSGGGGSQ TVVTQEPSLT VSPGGTVTLT CGSSTGAVTS
            GNYPNWVQQK PGQAPRGLIG GTKFLAPGTP ARFSGSLLGG KAALTLSGVQ PEDEAEYYCV
            LWYSNRWVFG GGTKLTVLHH HHHH
            (Disulfide bridge: 22-96, 159-224, 271-347, 411-479)
  TYPE      Peptide
EFFICACY    Antineoplastic
  TYPE      Monoclonal antibody
COMMENT     Treatment of multiple myeloma
TARGET      TNFRSF17 (BCMA, CD269) [HSA:608] [KO:K05153]
  PATHWAY   hsa04060(608)  Cytokine-cytokine receptor interaction
            hsa04672(608)  Intestinal immune network for IgA production
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Tumor necrosis factor receptors
                TNFRSF17 (BCMA, CD269)
                 D12010  Pacanalotamab (USAN)
DBLINKS     CAS: 2251756-52-0
///
